Chemo Pharma Laboratories Ltd
CHEMOPHChemo Pharma Laboratories Ltd
CHEMOPHPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
15.30 | 1.51 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Chemo Pharma Laboratories Limited is in negotiation to some other company and rehab to acquire business in power and chemicals. The Company was engaged in pharmaceuticals and bulk drugs business.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 0.49 | 5.61 | 1.11 | 0.82 | 1.00 | 0.67 | 0.79 | 0.30 | 1.84 | 1.88 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 | ||||||||||
Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
Employee Cost | 0.03 | 0.06 | 0.13 | 0.21 | 0.15 | 0.09 | 0.14 | 0.07 | 0.02 | |||||||||||
Selling & Administrative Expenses | 0.14 | 0.16 | 0.21 | 0.30 | 0.26 | 0.16 | 0.22 | 0.13 | 0.16 | |||||||||||
Operating & Other expenses | 0.00 | 0.05 | 0.00 | 0.02 | 0.05 | 0.08 | 0.04 | 0.00 | 0.00 | |||||||||||
EBITDA | 0.32 | 5.34 | 0.77 | 0.26 | 0.52 | 0.34 | 0.39 | 0.10 | 1.66 | 1.70 | ||||||||||
Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | — | ||||||||||
PBIT | 0.32 | 5.34 | 0.77 | 0.26 | 0.50 | 0.32 | 0.37 | 0.09 | 1.65 | 1.70 | ||||||||||
Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | — | ||||||||||
PBT | 0.32 | 5.34 | 0.77 | 0.26 | 0.50 | 0.32 | 0.37 | 0.08 | 1.65 | 1.70 | ||||||||||
Taxes & Other Items | 0.10 | 0.65 | 0.66 | 0.05 | 0.08 | 0.06 | -0.20 | 0.03 | 0.44 | 0.44 | ||||||||||
Net Income | 0.22 | 4.69 | 0.11 | 0.21 | 0.42 | 0.26 | 0.57 | 0.05 | 1.21 | 1.26 | ||||||||||
EPS | 1.47 | 31.27 | 0.73 | 1.40 | 2.80 | 1.73 | 3.80 | 0.33 | 8.07 | 8.40 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Chemo Pharma Laboratories Ltd | 15.93 | 1.51 | — |
Sun Pharmaceutical Industries Ltd | 45.35 | 6.47 | 0.75% |
Cipla Ltd | 28.51 | 4.38 | 0.89% |
Torrent Pharmaceuticals Ltd | 68.45 | 16.54 | 0.84% |
Price Comparison
Compare CHEMOPH with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
CHEMOPH has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Net profit of Chemo Pharma Laboratories rose 38.64% to Rs 0.61 crore in the quarter ended September 2024 as against Rs 0.44 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live
Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on 28 October 2024.Powered by Capital Market - Live
Chemo Pharma Laboratories announced that the 82th Annual General Meeting (AGM) of the company will be held on 23 September 2024.Powered by Capital Market - Live
Chemo Pharma Laboratories standalone net profit declines 34.21% in the June 2024 quarter
Net profit of Chemo Pharma Laboratories declined 34.21% to Rs 0.25 crore in the quarter ended June 2024 as against Rs 0.38 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live
Chemo Pharma Laboratories standalone net profit rises 10.00% in the September 2021 quarter
Chemo Pharma Laboratories standalone net profit declines 62.50% in the June 2021 quarter
Chemo Pharma Laboratories reports standalone net profit of Rs 0.02 crore in the March 2021 quarter
Chemo Pharma Laboratories standalone net profit declines 42.86% in the December 2020 quarter
BRIEF-Chemo Pharma Laboratories To Consider & Appoint Bhavin Sheth As CEO - Investing.com India
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 17.54%, vs industry avg of 9.03%
Constant Market Share
Over the last 5 years, market share stayed at 0%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 41.94%, vs industry avg of 15.27%